Peptide Library

FDA-approved

Bones & muscles

Etelcalcetide

Evidence

FDA approved

Class

Calcimimetic peptide

/

Etelcalcetide

KEY TAKEAWAY

Etelcalcetide is a synthetic peptide that mimics calcium at the calcium-sensing receptor. It is sold as Parsabiv. The FDA approved etelcalcetide (Parsabiv) in 2017 for secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Calcimimetic peptide

Approved for

Secondary hyperparathyroidism in adults on hemodialysis

Key fact

The FDA approved etelcalcetide (Parsabiv) in 2017 for secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis.

Route

Intravenous injection at the end of dialysis

Evidence strength

FDA approved

What it is

What it is

Etelcalcetide is a synthetic peptide that mimics calcium at the calcium-sensing receptor. It is sold as Parsabiv.

How it works

How it works

It activates the calcium-sensing receptor on the parathyroid gland, which lowers the release of parathyroid hormone.

Regulatory status

Regulatory status

The FDA approved etelcalcetide (Parsabiv) in 2017 for secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis.

What it is used for

What it is used for

Secondary hyperparathyroidism in adults on hemodialysis.

Side effects and risks

Side effects and risks

Low blood calcium, nausea, vomiting and muscle spasms are the main effects.

Citations

Citations

U.S. FDA prescribing information for Etelcalcetide. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo